These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 679460)

  • 1. Development and evaluation of a glucose analyzer for a glucose controlled insulin infusion system ((Biostator).
    Fogt EJ; Dodd LM; Jenning EM; Clemens AH
    Clin Chem; 1978 Aug; 24(8):1366-72. PubMed ID: 679460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the BIOSTATOR systems glucose analyzer.
    Fogt EJ; Dodd LM; Eddy AR; Jenning E; Clemens AH
    Horm Metab Res Suppl; 1979; (8):18-24. PubMed ID: 295037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feedback control dynamics for glucose controlled insulin infusion system.
    Clemens AH
    Med Prog Technol; 1979 Jun; 6(3):91-8. PubMed ID: 481365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of Biostator, a Glucose Controlled Insulin Infusion System (GCIIS).
    Clemens AH; Chang PH; Myers RW
    Horm Metab Res; 1977; Suppl 7():23-33. PubMed ID: 873440
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the clinical importance of the constants used in the algorithm of an artificial B-cell (Biostator).
    Ratzmann KP; Jutzi E; Albrecht G
    Z Exp Chir Transplant Kunstliche Organe; 1983; 16(5):270-6. PubMed ID: 6359740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An artificial betacell: assessment of the glucose analyser, infusion system and optimization of constants for the algorithms.
    Christiansen JS; Svendsen PA; Søegaard U; Frandsen M; Mathiesen E; Winther K; Deckert T
    Scand J Clin Lab Invest; 1981 Nov; 41(7):647-54. PubMed ID: 7041239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics.
    Mayfield RK; Sullivan FM; Colwell JA; Wohltmann HJ
    Diabetes; 1983 Oct; 32(10):908-14. PubMed ID: 6352376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the co-immobilized hexokinase/glucose-6-phosphate dehydrogenase method for glucose, as adapted to the Technicon SMAC.
    Garber CC; Feldbruegge D; Miller RC; Carey RN
    Clin Chem; 1978 Jul; 24(7):1186-90. PubMed ID: 657501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portable continuous blood glucose analyzer.
    Hakanson H
    Methods Enzymol; 1988; 137():319-26. PubMed ID: 3287093
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetic determination of serum glucose by use of the hexokinase/glucose-6-phosphate dehydrogenase method.
    Deeg R; Kraemer W; Ziegenhorn J
    J Clin Chem Clin Biochem; 1980 Jan; 18(1):49-52. PubMed ID: 7359090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin needs of insulin-dependent diabetics during biostator control and subcutaneous use of insulin].
    Petkova M; Khristov V; Tsanev A
    Vutr Boles; 1990; 29(1):74-7. PubMed ID: 2204207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma glucose measurement with the Yellow Springs Glucose Analyzer.
    Chua KS; Tan IK
    Clin Chem; 1978 Jan; 24(1):150-2. PubMed ID: 618647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses.
    Owen OE; Reichard GA; Markus H; Boden G; Mozzoli MA; Shuman CR
    J Clin Invest; 1973 Oct; 52(10):2606-16. PubMed ID: 4729054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control algorithms for artificial beta cell.
    Clemens AH
    Horm Metab Res Suppl; 1979; (8):35-8. PubMed ID: 395086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of an artificial B-cell in clinic and experimental medicine].
    Fischer U; Bruns W; Jutzi E; Ratzmann KP; Abel P; Bombor H; Salzsieder E; Freyse EJ
    Z Gesamte Inn Med; 1981 Jan; 36(1):19-26. PubMed ID: 7013292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin oscillations per se do not affect glucose turnover parameters in normal man.
    Paolisso G; Scheen AJ; Verdin EM; Luyckx AS; Lefebvre PJ
    J Clin Endocrinol Metab; 1986 Aug; 63(2):520-5. PubMed ID: 3522623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS; Svendsen PA; Deckert T
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a multichannel electrochemical centrifugal analyzer.
    Cho HK; Lee YH; Couch RA; Jagadeesh JM; Olson CL
    Clin Chem; 1982 Sep; 28(9):1956-61. PubMed ID: 7127810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interlaboratory comparison of enzymatic methods for serum glucose determination.
    Gochman N; Ryan WT; Sterling RE; Widdowson GM
    Clin Chem; 1975 Mar; 21(3):356-61. PubMed ID: 1112045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose controlled insulin infusion system (Biostator) application during surgery for a presumed pancreatic microinsulinoma.
    Massi-Benedetti M; Noy G; Johnston ID; Worth R; Alberti KG
    Diabete Metab; 1981 Mar; 7(1):41-4. PubMed ID: 6263727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.